PAM-50 predicts local recurrence after breast cancer surgery in postmenopausal patients with ER+/HER2- disease: results from 1204 patients in the randomized ABCSG-8 trial.

F Fitzal; M Filipits; C Fesl; M Rudas; Richard Greil; M Balic; F Moinfar; W Herz; P Dubsky; R Bartsch; S Ferree; C Schaper; M Gnant

doi:10.1093/bjs/znaa089

PAM-50 predicts local recurrence after breast cancer surgery in postmenopausal patients with ER+/HER2- disease: results from 1204 patients in the randomized ABCSG-8 trial.

F Fitzal, M Filipits, C Fesl, M Rudas, Richard Greil (Co-author), M Balic, F Moinfar, W Herz, P Dubsky, R Bartsch, S Ferree, C Schaper, M Gnant

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

23 Citations (Web of Science)

Original language	English
Pages (from-to)	308-314
Journal	THE BRITISH JOURNAL OF SURGERY
Volume	108
Issue number	3
DOIs	https://doi.org/10.1093/bjs/znaa089
Publication status	Published - 2021

Keywords

LUMPECTOMY PLUS TAMOXIFEN
PAM50 RISK
CONSERVING SURGERY
DISTANT RECURRENCE
AUSTRIAN BREAST
ENDOCRINE THERAPY
WOMEN
IRRADIATION
OLDER
SCORE

Access to Document

10.1093/bjs/znaa089

Cite this

Fitzal, F., Filipits, M., Fesl, C., Rudas, M., Greil, R., Balic, M., Moinfar, F., Herz, W., Dubsky, P., Bartsch, R., Ferree, S., Schaper, C., & Gnant, M. (2021). PAM-50 predicts local recurrence after breast cancer surgery in postmenopausal patients with ER+/HER2- disease: results from 1204 patients in the randomized ABCSG-8 trial. THE BRITISH JOURNAL OF SURGERY, 108(3), 308-314. https://doi.org/10.1093/bjs/znaa089

@article{13488c35899440a29fb6d583e72ec192,

title = "PAM-50 predicts local recurrence after breast cancer surgery in postmenopausal patients with ER+/HER2- disease: results from 1204 patients in the randomized ABCSG-8 trial.",

keywords = "LUMPECTOMY PLUS TAMOXIFEN, PAM50 RISK, CONSERVING SURGERY, DISTANT RECURRENCE, AUSTRIAN BREAST, ENDOCRINE THERAPY, WOMEN, IRRADIATION, OLDER, SCORE",

author = "F Fitzal and M Filipits and C Fesl and M Rudas and Richard Greil and M Balic and F Moinfar and W Herz and P Dubsky and R Bartsch and S Ferree and C Schaper and M Gnant",

note = "Greil: third Medical Department with Haematology and Oncology, Paracelsus Medical University , Salzburg, Austria ",

year = "2021",

doi = "10.1093/bjs/znaa089",

language = "English",

volume = "108",

pages = "308--314",

journal = "THE BRITISH JOURNAL OF SURGERY",

issn = "0007-1323",

publisher = "Wiley Verlag ",

number = "3",

}

Fitzal, F, Filipits, M, Fesl, C, Rudas, M, Greil, R, Balic, M, Moinfar, F, Herz, W, Dubsky, P, Bartsch, R, Ferree, S, Schaper, C & Gnant, M 2021, 'PAM-50 predicts local recurrence after breast cancer surgery in postmenopausal patients with ER+/HER2- disease: results from 1204 patients in the randomized ABCSG-8 trial.', THE BRITISH JOURNAL OF SURGERY, vol. 108, no. 3, pp. 308-314. https://doi.org/10.1093/bjs/znaa089

TY - JOUR

T1 - PAM-50 predicts local recurrence after breast cancer surgery in postmenopausal patients with ER+/HER2- disease: results from 1204 patients in the randomized ABCSG-8 trial.

AU - Fitzal, F

AU - Filipits, M

AU - Fesl, C

AU - Rudas, M

AU - Greil, Richard

AU - Balic, M

AU - Moinfar, F

AU - Herz, W

AU - Dubsky, P

AU - Bartsch, R

AU - Ferree, S

AU - Schaper, C

AU - Gnant, M

N1 - Greil: third Medical Department with Haematology and Oncology, Paracelsus Medical University , Salzburg, Austria

PY - 2021

Y1 - 2021

KW - LUMPECTOMY PLUS TAMOXIFEN

KW - PAM50 RISK

KW - CONSERVING SURGERY

KW - DISTANT RECURRENCE

KW - AUSTRIAN BREAST

KW - ENDOCRINE THERAPY

KW - WOMEN

KW - IRRADIATION

KW - OLDER

KW - SCORE

U2 - 10.1093/bjs/znaa089

DO - 10.1093/bjs/znaa089

M3 - Original Article

C2 - 33608712

SN - 0007-1323

VL - 108

SP - 308

EP - 314

JO - THE BRITISH JOURNAL OF SURGERY

JF - THE BRITISH JOURNAL OF SURGERY

IS - 3

ER -